Evidence map›Paper›PMID 33393927›Full record

ArticleJMIR research protocols2021

Effectiveness of the Use of Augmented Reality in Teaching the Management of Anaphylactic Shock at the Primary Care Level: Protocol for a Randomized Controlled Trial.

Zalika Klemenc-Ketis, Antonija Poplas Susič, Nina Ružić Gorenjec, Špela Miroševič, Uroš Zafošnik, Polona Selič, Špela Tevžič

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zalika Klemenc-KetisDepartment of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-0270-1754
Antonija Poplas SusičDepartment of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-4328-3333
Nina Ružić GorenjecLjubljana Community Health Centre, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-8505-1437
Špela MiroševičDepartment of Family Medicine, Faculty of Medicine, University of Maribor, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-5004-0607
Uroš ZafošnikDepartment of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-9334-2947
Polona SeličDepartment of Family Medicine, Faculty of Medicine, University of Maribor, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-5949-0580
Špela TevžičDepartment of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0001-5468-0564
University of Ljubljana · SIUniversity of Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAugmented reality (AR) has benefits and feasibility in emergency medicine, especially in the clinical care of patients, in operating rooms and inpatient facilities, and in the education and training of emergency care providers, but current research on this topic is sparse.

objectiveThe primary objective is to evaluate the short-term and long-term effectiveness of the use of AR in the treatment of patients with anaphylactic shock. The secondary objectives are to evaluate the safety in the treatment of patients with anaphylactic shock, evaluate the short-term and long-term effectiveness of stress management in this process, and determine the experiences and attitudes towards the use of AR in education.

methodsThe study will be conducted in 3 phases. In the first phase, we will develop and test the scenario for simulation of anaphylactic shock and the evaluation scale for assessing the effect of the intervention. In the second phase, a single-blinded, randomized controlled trial will be conducted. In the third phase, the use of AR in teaching the management of anaphylactic shock using focus groups will be evaluated qualitatively. All participants will participate in a 1-day training program consisting of a lecture on emergency care and anaphylactic shock as well as exercises in manual dexterity (aspiration, airway management, alternative airway management, artificial respiration, chest compressions, safe defibrillation, oxygen application, use of medication during emergency care). The test group will also focus on education about anaphylactic shock in AR (the intervention). The main outcome will be the evaluation of the participants' performance in coping with a simulated scenario of anaphylactic shock using a high-fidelity simulator (simulator with high levels of realism) and a standardized patient in an educational and clinical environment. The study will be conducted with primary care physicians.

resultsA scenario for the simulation with a high-fidelity simulator and standardized patient has already been developed. For the time being, we are developing an evaluation scale and starting to recruit participants. We plan to complete the recruitment of participants by the end of December 2020, start the randomized controlled trial in January 2021, and finish 1 year later. The first results are expected to be submitted for publication in 2021.

conclusionsThis will be the first study to evaluate the effectiveness of the use of AR in medical teaching. Specifically, it will be based on a clinical case of anaphylactic shock at the primary care level. With our study, we also want to evaluate the translation of these educational results into clinical practice and assess their long-term impact.

trial registrationISRCTN Registry ISRCTN58047410; http://www.isrctn.com/ISRCTN58047410. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/22460.

Indexed as

augmented realityeducationemergency medicineprimary health care

Identifiers

PMID33393927
PMCPMC7813631
OpenAlexW3098671940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.